JP2019521704A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521704A5 JP2019521704A5 JP2019516099A JP2019516099A JP2019521704A5 JP 2019521704 A5 JP2019521704 A5 JP 2019521704A5 JP 2019516099 A JP2019516099 A JP 2019516099A JP 2019516099 A JP2019516099 A JP 2019516099A JP 2019521704 A5 JP2019521704 A5 JP 2019521704A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- nucleic acid
- amino acid
- cdr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662346324P | 2016-06-06 | 2016-06-06 | |
| US62/346,324 | 2016-06-06 | ||
| US201662396767P | 2016-09-19 | 2016-09-19 | |
| US62/396,767 | 2016-09-19 | ||
| PCT/US2017/036178 WO2017214167A1 (en) | 2016-06-06 | 2017-06-06 | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521704A JP2019521704A (ja) | 2019-08-08 |
| JP2019521704A5 true JP2019521704A5 (https=) | 2020-07-16 |
| JP7070932B2 JP7070932B2 (ja) | 2022-05-18 |
Family
ID=59071115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019516099A Active JP7070932B2 (ja) | 2016-06-06 | 2017-06-06 | Ｂａｆｆ－ｒ標的化キメラ抗原受容体修飾ｔ細胞及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11161908B2 (https=) |
| EP (1) | EP3464371A1 (https=) |
| JP (1) | JP7070932B2 (https=) |
| KR (6) | KR102584944B1 (https=) |
| CN (2) | CN109311991B (https=) |
| AU (2) | AU2017277269C1 (https=) |
| CA (1) | CA3026640A1 (https=) |
| IL (4) | IL308798A (https=) |
| SG (1) | SG11201810887UA (https=) |
| WO (1) | WO2017214167A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| EP3439675A4 (en) | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| IL308798A (en) | 2016-06-06 | 2024-01-01 | Univ Texas | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof |
| WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| AU2019225174B2 (en) | 2018-02-23 | 2025-11-20 | Endocyte, Inc. | Sequencing method for CAR T cell therapy |
| CN121405815A (zh) * | 2018-12-19 | 2026-01-27 | 希望之城 | Baff-r双特异性t细胞衔接子抗体 |
| CN113874391B (zh) * | 2019-02-20 | 2025-10-28 | 希望之城公司 | 靶向baff-r/cd19的嵌合抗原受体修饰的t细胞及其用途 |
| US12023354B2 (en) | 2019-05-31 | 2024-07-02 | Case Western Reserve University | Targeting B cell activating factor receptor (BAFF-R) using ligand-based chimeric antigen receptor (CAR)-T cells |
| EP4041294A4 (en) * | 2019-10-01 | 2024-10-02 | Case Western Reserve University | TARGETING B-CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS |
| WO2021163989A1 (en) | 2020-02-21 | 2021-08-26 | Yinnuolai Biotech Ltd. | Anti-baff receptor antibodies and uses thereof |
| CN111499723B (zh) * | 2020-05-28 | 2021-04-09 | 广州百暨基因科技有限公司 | 一种嵌合抗原受体及其应用 |
| TW202300520A (zh) * | 2021-05-19 | 2023-01-01 | 大陸商上海詩健生物科技有限公司 | 特異性識別baff-r的嵌合抗原受體分子及其應用 |
| EP4376859A4 (en) | 2021-07-29 | 2025-07-30 | Sonoma Biotherapeutics Inc | SYNOVIAL EXTRACELLULAR MATRIX-SPECIFIC CHIMERIC ANTIGEN RECEPTOR FOR TARGETING REGULATORY T CELLS TO TREAT AUTOIMMUNE DISEASES |
| US20250319130A1 (en) * | 2022-06-01 | 2025-10-16 | Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute | Recombinant receptors binding b cell activation factor receptor and uses thereof |
| CN116041515A (zh) * | 2022-09-20 | 2023-05-02 | 南京驯鹿医疗技术有限公司 | 一种靶向baff-r抗原的全人源抗体、单链抗体、抗原结合片段 |
| CN116143943B (zh) * | 2022-10-31 | 2023-09-01 | 邦恩泰(山东)生物医药科技集团股份有限公司 | 一种靶向baffr嵌合抗原受体、car-t细胞及应用 |
| WO2025006795A1 (en) * | 2023-06-30 | 2025-01-02 | Board Of Regents, The University Of Texas System | Tsyn-seq: a t cell synapse-based tumor antigen identification platform |
| CN117050195B (zh) * | 2023-10-13 | 2023-12-19 | 旭和（天津）医药科技有限公司 | 一种靶向baffr嵌合抗原受体、car-t细胞和应用 |
| DE212024000246U1 (de) | 2023-10-27 | 2026-03-12 | Lg Energy Solution, Ltd. | Elektrodenübergabevorrichtung |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| WO1993012227A1 (en) | 1991-12-17 | 1993-06-24 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US6066718A (en) | 1992-09-25 | 2000-05-23 | Novartis Corporation | Reshaped monoclonal antibodies against an immunoglobulin isotype |
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| CN101120021A (zh) * | 2004-12-31 | 2008-02-06 | 基因技术公司 | 结合br3的多肽及其用途 |
| US9163258B2 (en) * | 2010-07-23 | 2015-10-20 | Fred Hutchinson Cancer Research Center | Method for the treatment of obesity |
| WO2014055657A1 (en) * | 2012-10-05 | 2014-04-10 | The Trustees Of The University Of Pennsylvania | Use of a trans-signaling approach in chimeric antigen receptors |
| CA2945388A1 (en) | 2014-04-23 | 2015-10-29 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) for use in therapy and methods for making the same |
| GB201412658D0 (en) * | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| KR20160016725A (ko) * | 2014-08-05 | 2016-02-15 | 주식회사 유영제약 | 암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포 |
| EP4628094A3 (en) * | 2016-06-06 | 2025-12-31 | City of Hope | BAFF-R ANTIBODIES AND THEIR USES |
| IL308798A (en) * | 2016-06-06 | 2024-01-01 | Univ Texas | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof |
-
2017
- 2017-06-06 IL IL308798A patent/IL308798A/en unknown
- 2017-06-06 SG SG11201810887UA patent/SG11201810887UA/en unknown
- 2017-06-06 JP JP2019516099A patent/JP7070932B2/ja active Active
- 2017-06-06 KR KR1020237012104A patent/KR102584944B1/ko active Active
- 2017-06-06 EP EP17731026.5A patent/EP3464371A1/en active Pending
- 2017-06-06 AU AU2017277269A patent/AU2017277269C1/en active Active
- 2017-06-06 KR KR1020227019986A patent/KR102522419B1/ko active Active
- 2017-06-06 KR KR1020237032847A patent/KR102815802B1/ko active Active
- 2017-06-06 CN CN201780035645.0A patent/CN109311991B/zh active Active
- 2017-06-06 CA CA3026640A patent/CA3026640A1/en active Pending
- 2017-06-06 US US16/307,443 patent/US11161908B2/en active Active
- 2017-06-06 WO PCT/US2017/036178 patent/WO2017214167A1/en not_active Ceased
- 2017-06-06 IL IL297925A patent/IL297925B2/en unknown
- 2017-06-06 KR KR1020197000160A patent/KR102356864B1/ko active Active
- 2017-06-06 IL IL263385A patent/IL263385B2/en unknown
- 2017-06-06 KR KR1020227002646A patent/KR102410360B1/ko active Active
- 2017-06-06 KR KR1020257017399A patent/KR20250084978A/ko active Pending
- 2017-06-06 CN CN202210970028.2A patent/CN115960251A/zh active Pending
- 2017-06-06 IL IL311985A patent/IL311985A/en unknown
-
2021
- 2021-09-03 US US17/466,968 patent/US12215162B2/en active Active
-
2024
- 2024-06-20 AU AU2024204218A patent/AU2024204218A1/en active Pending
- 2024-11-25 US US18/958,507 patent/US20250092149A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019521704A5 (https=) | ||
| JP7390345B2 (ja) | アゴニスト性ｔｎｆ受容体結合物質 | |
| JP2020114264A5 (https=) | ||
| JP2021177771A5 (https=) | ||
| JP2018508215A5 (https=) | ||
| JP2018508219A5 (https=) | ||
| JP2019511212A5 (https=) | ||
| JP2021531826A5 (https=) | ||
| JP2019513394A5 (https=) | ||
| JP2019527557A5 (https=) | ||
| JP2021087455A5 (https=) | ||
| JP2020511136A5 (https=) | ||
| RU2018105963A (ru) | Антитело против глипикана-3 и его применение | |
| JP2018029594A5 (https=) | ||
| JP2015527366A5 (https=) | ||
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| RU2018113510A (ru) | Химерные рецепторы антигена, нацеленные на psca | |
| JP2019527537A5 (https=) | ||
| JP2020529841A5 (https=) | ||
| JP2017513478A5 (https=) | ||
| JP2019515646A5 (https=) | ||
| JP2016514457A5 (https=) | ||
| JP2020513754A5 (https=) | ||
| JP2019528769A5 (https=) | ||
| JP2023534808A5 (https=) |